Mycophenolate Sandoz 250mg

Mycophenolate Sandoz is a generic pharmaceutical product containing mycophenolate mofetil, used primarily as an immunosuppressant to prevent organ rejection following transplants. The brand Sandoz is one of the world's leading manufacturers of generic and biosimilar medicines.

Originally founded in Switzerland, Sandoz became a household name in the pharmaceutical industry before merging with Ciba-Geigy to form Novartis in 1996. However, in late 2023, Sandoz was successfully spun off as a fully independent, publicly-traded company.

Manufacturing for Sandoz products occurs across a vast global network of facilities, including significant sites in Europe and Asia. The packaging shown indicates distribution in the Australian and New Zealand markets, though the API and finished dosage forms are typically produced in multiple locations to support international supply chains.